M&A Deal Summary |
|
|---|---|
| Date | 2024-01-11 |
| Target | Galvanize Therapeutics - Electrophysiology Technology Division |
| Sector | Healthcare Services |
| Buyer(s) | CardioFocus |
| Sellers(s) | Galvanize Therapeutics |
| Deal Type | Divestiture |
SEARCH BY
CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation, the most common heart arrhythmia. CardioFocus is based in Marlborough, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 2015 |
| Sector | Medical Products |
Galvanize Therapeutics is a provider of energy-based medical device technology that impacts biologic processes. Galvanize Therapeutics was founded in 2015 and is based in San Carlos, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
